Influences of degradability,bioactivity, and biocompatibility of the calcium sulfate content on a calcium sulfate/poly(amino acid) biocomposite for orthopedic reconstruction

The inorganic content in a bioceramic/polymer composite is considered to play an important role in promoting bone healing after implantation in vivo. In this study, two calcium sulfate/poly(amino acid) (CS/PAA) composites with CS content proportions of 50% (mass fraction, 50CS/PAA) and 65% (65CS/PAA) were synthesized via the in situ melting polymerization method, and the degradability, bioactivity, and biocompatibility of the composites were evaluated. The results indicated that 41.5% of weight loss of the 50CS/PAA was observed after soaking in simulated body fluid (SBF) for 16 weeks, whereas 56.2% of weight loss of the 65CS/PAA was observed. These results suggested that the CS content in the composite affected the degradability of the composite. After being soaked in SBF for 1 week, formation of an apatite layer was observed on the surfaces of both composites without obvious differences. The co‐culture results of the composites and the MG‐63 cells confirmed that 65CS/PAA exhibited higher proliferation and a higher alkaline phosphatase (ALP) activity than did 50CS/PAA. The implantations in bone defects of rabbits for 3 months revealed that both composites had good biocompatibility and were capable of guiding new bone formation without causing any inflammation. However, faster degradability of the 65CS/PAA composite was observed in vivo, indicating that the higher CS content in the composite results in higher degradability. In conclusion, the CS content in the composite for orthopedic reconstruction has distinct effects on the degradability, OD value, and ALP activity of the composites, whereas it has little effect on the bioactivity and bone formation. POLYM. COMPOS., 37:1886–1894, 2016. © 2015 Society of Plastics Engineers     

Microstructural,mechanical properties and strengthening mechanism of DLP produced β-tricalcium phosphate scaffolds by incorporation of MgO/ZnO/58S bioglass

The inherent brittleness of bioceramics restricts their applications in load-bearing implant, although they possess good biocompatibility and bioactivity. ZnO, MgO and 58S bioglass (BG) were incorporated as additives to further improve the mechanical properties and biocompatibility of β-TCP and ZnO/MgO/BG-β-TCP composite scaffolds were manufactured via digital light processing (DLP). The composite with the best comprehensive performance was selected for degradation behavior and biocompatibility evaluation. The effects of different proportions of ZnO/MgO/BG on mechanical strength were analyzed and ZnO0·5/MgO1/BG2-β-TCP (ZMBT) samples exhibited superior mechanical strength. The improvement by 272% and 99% respectively was achieved in fracture toughness and compressive strength with the optimal recipe. The enhancement effect is realized through phase transition, alterative sliding actions and transgranular fracture to effectively prevent the load transfer combining the functions of bioglass and metal oxide. ZMBT scaffolds exhibited a more desirable pH environment and an enhanced ability of apatite-mineralization formation, meanwhile Si⁴⁺, Mg²⁺ and Zn²⁺ were gradually released from scaffolds. Furthermore, in vitro evaluation indicated that ZMBT scaffolds presented not only excellent cell attachment, proliferation, alkaline phosphatase (ALP) activity, but they up-regulated osteogenic gene (ALP, OCN, Runx2). These results suggest that the addition of ZnO/MgO/BG to DLP-printed β-TCP scaffolds offer a smart strategy to fabricate porous scaffolds with conspicuously better biological and physicochemical properties including compressive strength, bioactivity, osteogenesis and osteogenesis-related gene expression. Metal-oxide and BG synergistically enhanced the mechanical and biological properties which make the ZMBT scaffolds a strong candidate for bone repair applications.     

The effect of tricalcium silicate incorporation on bioactivity,injectability, and mechanical properties of calcium sulfate/bioactive glass bone cement

The conventional Polymethyl methacrylate (PMMA) bone cement is not biodegradable and not bioactive to bond with the native bone and causes tissue necrosis resulting from its high exothermic polymerization. Hence, biodegradable bioactive bone cements with suitable setting time and mechanical properties should be introduced. In this study, novel bioactive bone cements containing Calcium Sulfate Hemihydrate (CSH), Bioactive Glass (BG), and Tricalcium Silicate (TSC) were developed. Firstly, CSH and BG binary system was optimized based on preliminary setting and mechanical tests. Secondly, the composite bioactive bone cements were obtained by adding different quantities of TCS to the optimized CS-BG (1.3:1 wt % ratio) system. All groups exhibited desirable handling properties, an initial setting time of lower than 15 min, injectability of greater than 85%, and controlled degradability. Moreover, they demonstrated initial compressive strength values of higher than 12 MPa, superior to trabecular bone. After 28 days of hydration, the compressive strength of the cement containing 30% TCS reached 51.04 MPa. Furthermore, the present bone cements showed favorable bioactivity and bone-bonding ability as a result of calcium carbonate and hydroxyapatite (HA) formation. Furthermore, this novel bone cement exhibited appropriate biocompatibility and mesenchymal stem cell attachment, suggesting its potential for clinical applications.     

Fabrication and characterization of bioactive glass (45S5)/titania biocomposites

Bioactive glass (BG) (45S5) has been used successfully as bone-filling material in orthopedic and dental surgery but its lean mechanical strength limits its applications in load-bearing positions. Approaches to strengthen these materials decreased their bioactivity. In order to realize the optimal matching between mechanical and bioactivity properties, bioactive glass (45S5) was reinforced by introducing titania (TiO₂) in anatase form and treated at 1000 °C to form new bioactive glass/titania biocomposites. The prepared biocomposites were assessed by XRD, FT-IR, mechanical properties and SEM. The results verified that the increase of titania percentage to BG powder enhanced gradually the mechanical data of the prepared biocomposites. SEM and FT-IRRS confirmed the presence of a rich bone-like apatite layer post-immersion on the composite surface. It has been found that the new BG/titania biocomposite materials especially those containing high content of titania have high bioactivity properties and compressive strength values comparable to cortical bone. Therefore, these biocomposite materials are promising for medical applications such as bone substitutes especially in load-bearing sites.     

Bioactivity of Zirconia-Toughened Glass-Ceramics

Bioactivity of zirconia-toughened glass-ceramic composites was evaluated by their surface reaction in simulated body fluid and the bonding strength to living bone. The composite containing 30 vol% zirconia showed high bioactivity, whereas that containing 50 vol% zirconia, extremely low. TEM observation indicated that Ca in the glass-ceramic particles reacted with the zirconia during sintering. It was found that the decrease in Ca in the particles degraded the bioactivity of the composite. In this study, the optimum composition was determined for high-strength and bioactive ceramic.     

Production of Hydroxyapatite/Bioactive Glass Biomedical Composites by the Hot-Pressing Technique

Biomedical composites of hydroxyapatite (HA) and bioactive glass (BG) have been difficult to obtain as a dense body without the undesirable occurrence of thermal reactions and phase degradation. Herein, HA–BG dense composites were produced by the hot-pressing technique. A range of HA–BG powder mixtures (30–50 wt% BG) was fully densified by hot pressing at temperatures as low as ∼700°–800°C. On the other hand, the HA–BG composites could not be densified by pressureless sintering because their composition was degraded due to a severe thermal reaction. The hot-pressed composites had significantly improved flexural strengths (∼60 MPa) as compared with those subjected to pressureless sintering (∼30 MPa) or the pure HA control (∼40 MPa). The hot-pressed HA–BG composites showed significantly enhanced bioactivity in a simulated body fluid, as well as osteoblast cell activity with respect to the pure HA, confirming their excellent in vitro biocompatibility.     

Fabrication of Hydroxyapatite with Bioglass Nanocomposite for Human Wharton’s-Jelly-Derived Mesenchymal Stem Cell Growing Substrate

Recently, composite scaffolding has found many applications in hard tissue engineering due to a number of desirable features. In this present study, hydroxyapatite/bioglass (HAp/BG) nanocomposite scaffolds were prepared in different ratios using a hydrothermal approach. The aim of this research was to evaluate the adhesion, growth, viability, and osteoblast differentiation behavior of human Wharton’s-jelly-derived mesenchymal stem cells (hWJMSCs) on HAp/BG in vitro as a scaffold for application in bone tissue engineering. Particle size and morphology were investigated by TEM and bioactivity was assessed and proven using SEM analysis with hWJMSCs in contact with the HAp/BG nanocomposite. Viability was evaluated using PrestoBlue^TM assay and early osteoblast differentiation and mineralization behaviors were investigated by ALP activity and EDX analysis simultaneously. TEM results showed that the prepared HAp/BG nanocomposite had dimensions of less than 40 nm. The morphology of hWJMSCs showed a fibroblast-like shape, with a clear filopodia structure. The viability of hWJMSCs was highest for the HAp/BG nanocomposite with a 70:30 ratio of HAp to BG (HAp70/BG30). The in vitro biological results confirmed that HAp/BG composite was not cytotoxic. It was also observed that the biological performance of HAp70/BG30 was higher than HAp scaffold alone. In summary, HAp/BG scaffold combined with mesenchymal stem cells showed significant potential for bone repair applications in tissue engineering.     

Fabrication of polymethyl methacrylate/polysulfone/nanoceramic composites for orthopedic applications

We report the fabrication of polymethyl methacrylate/polysulfone/nanohydroxyapatite (PMMA/PSu/nHA) and PMMA/PSu/nanotitania (PMMA/PSu/nTiO₂) composites using N′N′‐methylene‐bis‐acrylamide (MBA) to crosslink PMMA and act as a blending agent. The composite was made porous by incorporating polyethylene glycol as the pore‐forming agent. The blend between PMMA and PSu was confirmed using Fourier transform infrared spectroscopy and thermogravimetric analysis (TGA). The surface morphology of the composites analyzed using scanning electronic microscopy (SEM) revealed the porous structure and the wide distribution of the fillers that were found to aggregate at higher concentrations. The maximum tensile strength observed for composites was with 5% nHA (23 MPa) and 7.5% TiO₂ (30 MPa). The TGA of the composites showed better thermal stability with increase in the filler concentrations. The X‐ray diffraction analysis showed that appearance of new peaks in the blend polymers indicating a strong interaction between PMMA and PSu. The surface of the composites was coated with amoxicillin and its efficiency was examined by the Zone of Inhibition test using Streptococcus mutans. The bioactivity of the composites was evaluated by immersing them in simulated body fluid and examining their surface for the formation of calcium‐phosphate layer using SEM and EDAX. Bioactivity was found to increase with increase in filler content. The in vitro biocompatibility of the composites, evaluated using monkey kidney epithelial cells by MTT assay showed that the composites containing nHA showed better cell viability than the composites with nTiO₂. The study showed that the composites with nTiO₂ exhibited better strength when compared with nHA composites while the later exhibited better biocompatibility. © 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013     

Investigation of bismuth doped bioglass/graphene oxide nanocomposites for bone tissue engineering

In this study, bismuth doped 45S5 nanobioactive bioglass (nBG) and graphene oxide (GO) nanocomposites were developed and characterized in terms of microstructural, mechanical, bioactivity and biological properties. Bismuth (Bi) - doped nBG was synthesized by sol-gel method and sintered at 600 °C for 2 h. Nanosized GO was homogeneously mixed with Bi doped bioglass at various ratios to prepare nanocomposites. Addition of Bi increased the density of nBG samples while a considerable decrease in density was observed for nanocomposites with GO incorporation. Bi improved the diametral tensile strength of nBG and addition of 2.5% GO to the composite also increased the diametral tensile strength of the nanocomposites. However, addition of more than 2.5% GO had negative effect on the diametral tensile strength of the composites. Bi doping to bioglass and its composite with GO increased the biocompatibility of 45S5 nBG in which 96.5BG1Bi2.5GO (containing 96.5% BG 1% Bi 2.5% GO in weight ratio) showed highest cell viability. Overall, it can be concluded that composites of Bi doped 45S5 nBG with GO hold promise as biomaterial for biomedical applications.     

Physicochemical,setting, rheological,and mechanical properties of a novel bio-composite based on apatite cement,bioactive glass,and alginate hydrogel

Calcium phosphate cements (CPC) have been widely investigated as bone substitutes, owing to their attractive features in terms of physicochemical and biocompatibility properties. However, the clinical applicability of this group of biomaterials is still critically limited by its poor strength and rheological properties in terms of injectability and cohesion. The present work aims to develop novel composite cement based on calcium phosphate cement (CPC) and bioactive glass (BG), associated with sodium alginate hydrogel (Alg). The composition, microstructure, setting, rheological, and mechanical properties of this composite cement were further investigated. Evaluation of setting properties showed that BG participates crucially in the setting reaction as a calcium and phosphate provider and serves as a setting accelerator. Thus, the setting time appears lower in these cements than in the reference CPC cement: it decreases from 75 to 42 min as the BG content increases from 10 to 25 wt% and is delayed from 42 to 73 min while the Alg amount augmented from 1 to 5 wt%. The rheological evaluation revealed that injectability was slightly improved with increasing BG content compared to the injectability of CPC, reaching a value close to 100% when combined with Alg hydrogel. The anti-washout property appeared to be weak for the CPC with or without BG, which are disintegrated in solution. The cohesiveness was significantly improved by introducing Alg hydrogel; furthermore, the addition of 5 wt% of alginate hydrogel induced an increase in the compressive strength about twice (7.2 MPa) higher than that of the reference CPC (4.0 MPa). According to the above findings, the addition of BG acts as a setting accelerator leading to a fast apatite formation, while the introduction of Alg hydrogel as a rheological promoting agent improves the injectability and cohesion. The combination of BG and Alg as additives increased the compressive strength compared to the reference cement.     

Preparation,properties and in vitro cellular response of multi-walled carbon nanotubes/bioactive glass/poly(etheretherketone) biocomposite for bone tissue engineering

Desired bone repair biomaterial must have good biocompatibility and suitable mechanical properties that are equivalent to those of human bones. In this study, multi-walled carbon nanotubes (MWCNTS) was designed to incorporate into bioactive glass/poly(etheretherketone) to fabricate a composite of multi-walled carbon nanotubes/bioactive glass/poly(etheretherketone) (MWCNTS/BG/PEEK) through a compounding and injection-molding process. The microstructures, mechanical properties, thermal stability and bioactivity of the ternary biocomposite, as well as preliminary cell responses of MC3T3-E1 osteoblast cells to this biomaterial, were investigated. The mechanical performance of ternary MWCNTS/BG/PEEK composite was vastly superior to binary BG/PEEK composite. More importantly, cell culture tests showed that cell adhesion, viability and differentiation of MC3T3-E1 cells were significantly promoted on the MWCNTS/BG/PEEK composite. Moreover, it was found that MWCNTS in composite further promoted cell metabolic vitality and osteogenic differentiation of osteoblast cells. Hence, this MWCNTS/BG/PEEK biomaterial may be used as a promising bone graft scaffold in dental and orthopedic applications.     

Physico-chemical and biological studies on three-dimensional porous silk/spray-dried mesoporous bioactive glass scaffolds

The incorporation of a bioactive inorganic phase in polymeric scaffolds is a good strategy for the improvement of the bioactivity and the mechanical properties, which represent crucial features in the field of bone tissue engineering. In this study, spray-dried mesoporous bioactive glass particles (SD-MBG), belonging to the binary system of SiO₂-CaO (80:20 mol%), were used to prepare composite scaffolds by freeze-drying technique, using a silk fibroin matrix. The physico-chemical and biological properties of the scaffolds were extensively studied. The scaffolds showed a highly interconnected porosity with a mean pore size in the range of 150 µm for both pure silk and silk/SD-MBG scaffolds. The elastic moduli of the silk and silk/SD-MBG scaffolds were 1.1±0.2 MPa and 6.9±1.0 MPa and compressive strength were 0.5±0.05 MPa and 0.9±0.2 MPa, respectively, showing a noticeable increase of the mechanical properties of the composite scaffolds compared to the silk ones. The contact angle value decreased from 105.3° to 71.2° with the incorporation of SD-MBG particles. Moreover, the SD-MBG incorporation countered the lack of bioactivity of the silk scaffolds inducing the precipitation of hydroxyapatite layer on their surface already after 1 day of incubation in simulated body fluid. The composite scaffolds showed good biocompatibility and a good alkaline phosphatase activity toward human mesenchymal stromal cells, showing the ability for their use as three-dimensional constructs for bone tissue engineering.     

Enhanced mechanical properties and hydrophilic behavior of magnesium oxide added hydroxyapatite nanocomposite: A bone substitute material for load bearing applications

Hydroxyapatite is a multifunctional biomaterial that combines biocompatibility and bioactivity for various biomedical applications such as bone repairing and bioimaging. In the present study nano-hydroxyapatite (n-HAp) was synthesized using microwave irradiation technique. Subsequently, the MgO was introduced into the n-HAp matrix and various bioactive compositions of HAp-MgO nanocomposites were fabricated. The structural, mechanical, in vivo cell viability, and in vivo imaging properties of these nanocomposites were studied. The XRD results show that the composites sintered at 1200 °C, n-HAp partially decomposed into beta-tricalcium phosphate (β-TCP). The sintered density of the composites varying from 2.72 ± 0.066 to 3.03 ± 0.093 g cm⁻³ with the addition of 0.0–2.0 wt % of MgO. As increasing the amounts of MgO, a remarkable increase in the mechanical properties of the composite was achieved. The composite HAp-1.0MgO exhibited the highest mechanical properties with a compressive strength of 111.20 ± 5 MPa, fracture toughness 136.98 ± 5 MJ/m³ and revealed much amplification than pure n-HAp. Thus, the addition of MgO acting as an excellent mechanical reinforcing agent. The surface morphology of the composites revealed a significant change in the porous surface to denser. The low contact angle revealed the considerable hydrophilic nature of the composite surface. The biological study of these nano-composites with Drosophila third instar larvae indicated comparable or more favorable biocompatibility in terms of cell viability. Also internalized by Drosophila third instar larvae exhibited fluorescence under green and red filters using epifluorescence microscopy. Thus, the fabricated HAp-MgO nanocomposites with excellent biological properties are expected to be a multifunctional bioactive material for bone tissue regeneration and cell imaging applications.     

Characterization of bioactive glass-coated carbon nanotubes prepared by solgel process

Due to its excellent bioactivity, bioactive glass (BG) is suitable for use as bone graft substitutes in biomedical applications. In this study, carbon nanotubes (CNT-COOH) served as templates for depositing bioactive glass based on 60SiO₂–36CaO–4P₂O₅ wt.% were synthesized via the solgel process. The BG and BG/CNT-COOH composites were treated at 300, 500, 700, and 900°C; their properties were also examined by X-ray diffraction, Fourier transform infrared spectroscopy, and scanning electron microscopy. The experimental results showed that BG/CNT-COOH composites treated at 500 and 700°C were amorphous and contained silicate nanocrystals. By altering precursor concentration, bioactive glass of various thicknesses was successfully solgel coated on CNT-COOH. Immersion of the BG/CNT-COOH composites in simulated body fluid solution and MG-63 cell culture assessment showed the 500°C treated BG/CNT-COOH exhibits excellent bioactivity.     

Bioactive superparamagnetic nanoparticles for multifunctional composite bone cements

Magnetite-based nanoparticles (NPs) were synthesized by co-precipitation process and coated with a thin layer of silica, eventually doped with calcium, by a modified Stöber method. The potential bioactive behavior of NPs was investigated by dipping samples in simulated body fluid (SBF) and analyzing them with Field-Emission Scanning Electron Microscope (FESEM) equipped with Energy Dispersive Spectroscopy (EDS). Silica-coated NPs displayed evidence of HAp grown on their surface and were then used as a filler for polymethyl methacrylate (PMMA)-based bone cement to impart bioactive and magnetic properties. The influence of the amount of magnetic NPs and the cement mixing method (manual or mechanical) were estimated in terms of NPs dispersion, compressive strength and bioactive behavior. The obtained data evidenced that both the NPs amount and the mixing method influenced the strength of the composites. A delay in the bioactivity was observed for manual mixed cement; moreover, mechanically mixed composites containing a low amount of NPs showed superparamagnetic behavior. These results suggest that the investigated composite bone cements are promising materials for the treatment of bone tumors and associated complications.     

Fabrication of fibrous poly (ɛ-caprolactone) nano-fibers containing cerium doped-bioglasses nanoparticles encapsulated collagen

Novel nanosized designed ceramic powders, cerium (Ce) doped bioglass (BG) with various doped Ce content, were synthesized by sol–gel method in order to be employed in the development of PCL fibrous scaffold for bone tissue engineering applications. Characterization techniques such as X-ray diffraction analysis, transmission electron microscopy, Fourier transform infrared spectroscopy, and energy-dispersive X-ray spectroscopy were employed to evaluate the developed Ce doped BG powders. The results confirmed successful doping of Ce inside BG structure. 0, 1, 3, and 10 wt% Ce doped 58S BG were successfully encapsulated in the collagen microspheres by water-in-oil emulsion method and the average particle size and hydrodynamic diameter of microspheres were determined using scanning electron microscopy and dynamic light scattering analysis, respectively. Next, 0, 1, 3, and 10 wt% Ce doped 58S BG encapsulated collagen microspheres were loaded inside the Poly(ɛ-caprolactone) fibrous scaffold and their in vitro bioactivity and biocompatibility properties were evaluated. The results of soaking samples in the simulated body fluid showed that all Ce doped 58S BG encapsulated collagen microspheres loaded PCL fibrous scaffold have acceptable bioactivity and apatite formation ability over time. The biocompatibility evaluation of developed scaffolds showed high viability and proliferation of MG63 cells cultured on the surface of 3% Ce doped 58S BG encapsulated collagen microsphere loaded in the PCL fibrous scaffold and its high potential ability for bone tissue engineering applications. These results potentially open new aspects for scaffolds aimed at the regeneration of bone defects.     

碳布增强聚芳基乙炔新防热材料

本文了新型高碳聚芳基乙炔树脂的成碳率及其碳布增强防热材料成型工艺,对复合材料的性能进行了表征。     

Influence of polyacrylic acid (PAA)/Na2HPO4 mixture on biphasic calcium phosphate cement: Enhancing strength and cell viability

This study has investigated the effect of combination of new liquid phase mixture of disodium hydrogen phosphate (Na₂HPO₄) and polyacrylic acid (PAA) on the compressive strength, setting time, bioactivity, and cytotoxicity of biphasic calcium phosphate cement. The PAA was known as one of water-soluble and biocompatible polymers to improve the mechanical performances of the bone cement, but it usually inhibits the phase conversion to hydroxyapatite after the cement has already set. The aim of this work was to evaluate the incorporation of the mixture of PAA and Na₂HPO₄ into biphasic cement. We have found the crucial concentration for adding PAA/Na₂HPO₄ at 30:70 v/v% to enhance the mechanical strength, cell viability, and maintain bioactivity. The phase composition and crosslinking reaction between PAA and alpha-tricalcium phosphate (α-TCP) powder were detected by XRD and FTIR techniques. The beta-tricalcium phosphate (β-TCP) was added in the formula to achieve the biphasic cement, which composed of β-TCP and apatite/calcium deficient-hydroxyapatite (CD-HA) in the final product. The biphasic granule commercial product was used as comparison in the cell viability test. This work had been confirmed that the cement was a nontoxic material. Therefore, our results suggest that the PAA/Na₂HPO₄ could be beneficial for further clinical applications.     

In vitro degradation behaviors of Poly-<Emphasis Type="SmallCaps">l</Emphasis>-lactide/bioactive glass composite materials in phosphate-buffered solution

In vitro degradation behaviors of composite materials composed of poly-l-lactide (PLLA) and bioactive glass (BG) were systematically investigated up to 20 weeks in phosphate-buffered solution (PBS) at 37 °C. The properties of PLLA/BG composites and PLLA materials, including weight loss, bending strength and modulus, shearing strength, polymer molecular weight and its distribution, and the morphologies, were investigated as a function of degradation time. The change of the pH value of the PBS media was also detected. The results showed that the presence of the bioactive glass modified the degradation of the matrix polymer. The degradation rate of the PLLA/BG composites was slower than the degradation rate of the sole PLLA materials.     

Biological evaluation of poly-l-lactic acid composite containing bioactive glass

Biodegradable and biocompatible materials are the basis for medical application. As an initial step for developing bone internal fixation materials, the biological evaluation of poly-l-lactic acid/bioactive glass (PLLA/BG) composite in vitro and in vivo, including the hemolysis test, pyrogen test, acute systemic toxicity test, genetic toxicity test, anaphylaxis test, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) test, direct cell culture and in vivo implant experiment, was performed. The results indicated that PLLA/BG composite showed no acute systemic toxicity, genetic toxicity, anaphylaxis reaction, and pyrogen reaction, and the hemolysis ratio was 0.39%. MTT assay indicated that no cytotoxic effect was observed for the PLLA/BG composite, and in addition, a significant increase in cellular activity compared to the negative control group was found. Excellent adhesion between fibroblast and PLLA/BG material was observed, the fibroblasts cultured on the PLLA/BG composite substrates revealed a higher proliferation and differentiation rate than those on the pure PLLA substrates. In vivo implant experiment showed that the PLLA/BG composite could maintain the mechanical properties during the course of fracture therapy, and the malleolar fracture of rabbits was healed in 8 weeks on the whole. Therefore, PLLA/BG composites have a promising biological response as a potential implant material.